HomeMEHCQ • OTCMKTS
add
23andMe Holding Co
Nakaraang pagsara
$4.24
Sakop ng araw
$4.05 - $4.39
Sakop ng taon
$0.47 - $10.81
Market cap
117.60M USD
Average na Volume
575.71K
P/E ratio
-
Dividend yield
-
Primary exchange
OTCMKTS
Mga balita tungkol sa merkado
Mga Financial
Income Statement
Kita
Net na kita
(USD) | Mar 2025info | Y/Y na pagbabago |
---|---|---|
Kita | 45.15M | -29.49% |
Gastos sa pagpapatakbo | 65.51M | -34.62% |
Net na kita | -99.35M | 52.43% |
Net profit margin | -220.04 | 32.54% |
Kita sa bawat share | — | — |
EBITDA | -45.06M | 35.08% |
Aktuwal na % ng binabayarang buwis | 0.00% | — |
Balance Sheet
Kabuuang asset
Kabuuang sagutin
(USD) | Mar 2025info | Y/Y na pagbabago |
---|---|---|
Cash at mga panandaliang investment | 38.25M | -82.33% |
Kabuuang asset | 159.89M | -59.54% |
Kabuuang sagutin | 186.64M | -9.68% |
Kabuuang equity | -26.74M | — |
Natitirang share | 27.54M | — |
Presyo para makapag-book | -4.37 | — |
Return on assets | -54.88% | — |
Return on capital | -230.70% | — |
Cash Flow
Net change in cash
(USD) | Mar 2025info | Y/Y na pagbabago |
---|---|---|
Net na kita | -99.35M | 52.43% |
Cash mula sa mga operasyon | -40.73M | -57.97% |
Cash mula sa pag-invest | -734.00K | 65.80% |
Cash mula sa financing | -529.00K | -126.45% |
Net change in cash | -41.99M | -61.95% |
Malayang cash flow | -82.91M | -285.64% |
Tungkol
23andMe Holding Co. is an American personal genomics and biotechnology company based in South San Francisco, California. It is best known for providing a direct-to-consumer genetic testing service in which customers provide a saliva sample that is laboratory analysed, using single nucleotide polymorphism genotyping, to generate reports relating to the customer's ancestry and genetic predispositions to health-related topics. The company's name is derived from the 23 pairs of chromosomes in a diploid human cell.
Founded in 2006, 23andMe soon became the first company to begin offering autosomal DNA testing for ancestry, which all other major companies now use. Its saliva-based direct-to-consumer genetic testing business was named "Invention of the Year" by Time in 2008.
The company had a previously fraught relationship with the United States Food and Drug Administration due to its genetic health tests; as of October 2015, DNA tests ordered in the US include a revised health component, per FDA approval. 23andMe has been selling a product with both ancestry and health-related components in Canada since October 2014, and in the UK since December 2014. Wikipedia
Itinatag
Abr 2006
Headquarters
Website
Mga Empleyado
261